Protein Assays for Clinical Studies
Clinical research starts with testing for safety and expands further to determine if the treatment is effective. Our protein profiling offerings can support Phase I, Phase II and Phase III clinical trials with monitoring pharmacokinetic (PK) and pharmacodynamic (PD) markers.
Analyses performed under GCP conditions
Simoa and Luminex profiling studies can be conducted under GCP conditions, RPPA can be offered under GCP-like conditions. We have been successfully audited by two top10 pharma companies and one top5 clinical CRO.
We serve all stages of drug development
We offer protein profiling services for different stages of drug development. The services vary from high-content protein profiling, high-throughput protein profiling, ultra-sensitive protein profiling, etc. For protein profiling in clinical studies, we offer services under GCP-like conditions.
Feel free to contact us at any point. We can help you find the right services for your needs.